Thailand accelerates investment in advanced medical innovation, aiming to become the ASEAN hub for ATMPs
The public and private sectors in Thailand are collaborating to fully invest in advanced medical technologies to elevate healthcare standards and improve the quality of life for the country's citizens, with a focus on integrating new innovations into comprehensive healthcare.
A key goal of this investment is to propel Thailand to become the regional hub for Advanced Therapy Medicinal Products (ATMPs) in ASEAN. These represent the most modern treatment technologies available today, such as cell therapy and gene therapy, used to treat complex diseases.
Development in this field will not only help Thai patients access highly effective treatments but will also build international confidence in Thailand's public health system. Furthermore, it will stimulate the economy by creating a modern medical industry capable of competing in the global market.
In the future, becoming an ATMP hub will help attract foreign investment and promote increased domestic research and development, which serves as a significant step toward making Thailand a sustainable and leading medical destination in the region.